Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris
Public ClinicalTrials.gov record NCT03303170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Randomized, Controlled, Evaluator-Blinded Study of the Safety and Effectiveness of Sebacia Microparticles as an Accessory to 1064 nm Nd:Yag Laser in the Treatment of Facial Inflammatory Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prospective, randomized, controlled, parallel group clinical study with blinded assessment evaluating Sebacia Microparticles (SM) with Nd:Yag laser in facial inflammatory acne vulgaris
Study identification
- NCT ID
- NCT03303170
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 25, 2017 (Actual)
- Primary completion
- Apr 10, 2018 (Actual)
- Completion
- Apr 10, 2018 (Actual)
- Last update posted
- Oct 14, 2019
2017 – 2018
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clear Dermatology & Aesthetics Center | Scottsdale | Arizona | 85255 | — |
| Scripps Health | San Diego | California | 92121 | — |
| Miami Dermatology & Laser Institute | Miami | Florida | 33173 | — |
| Meridian Clinical Research | Savannah | Georgia | 31406 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Dermatology, Laser & Vein Institute | Charlotte | North Carolina | 28207 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| International Clinical Research | Murfreesboro | Tennessee | 37130 | — |
| Austin Institute for Clinical Research | Austin | Texas | 78660 | — |
| The Center for Skin Research | Katy | Texas | 77494 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03303170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2019 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03303170 live on ClinicalTrials.gov.